Skip to main content

Day: September 10, 2021

CHNC Expands Distribution of Its Educational Training Programs Through Leading Online Digital Distributors

Digital Content Now Available on Amazon, Walmart, Barnes & Noble, Kobo, Sympla and Many Others HOUSTON, TX, Sept. 10, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – China Infrastructure Construction Corp. (dba Cannabis Bioscience International Holdings), announced today that it has dramatically bolstered the distribution strategy for its educational videos, eBooks and audiobooks by making them available for purchase on the world’s leading online retail sites such as Amazon Prime, Walmart, and Barnes & Noble. Additionally, it has partnered with approximately 30 online educational companies such as Sympla, Simpliv Learning, Teachlr, Tuellus, and others to distribute its digital content. The company’s online cannabis educational platform, Pharmacology University, is made up of a team of professionals with expertise in the areas...

Continue reading

Diana Shipping Inc. Announces Time Charter Contract for m/v Myrto With Solebay

ATHENS, Greece, Sept. 10, 2021 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership of dry bulk vessels, today announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with Solebay Shipping Transocean Company Limited, for one of its Kamsarmax dry bulk vessels, the m/v Myrto. The gross charter rate is US$28,500 per day, minus a 5% commission paid to third parties, for a period until minimum August 15, 2022 up to maximum October 15, 2022. The charter commenced earlier today. The m/v Myrto was chartered, as previously announced, to Cargill International S.A., Geneva, at a gross charter rate of US$10,000 per day, minus a 4.75% commission paid to third parties. The “Myrto” is a 82,131 dwt Kamsarmax dry bulk vessel built...

Continue reading

CHAR Announces Exclusive Technology Partnership

TORONTO, Sept. 10, 2021 (GLOBE NEWSWIRE) — CHAR Technologies Ltd. (“CHAR” or “Company”) (YES – TSXV) announces the signing of an exclusive technology licensing agreement (“Agreement”) with CHAR’s principal kiln technology supplier, Anergy, a global waste transformation leader. This Agreement strengthens CHAR’s relationship with Anergy to continue our collaboration on technology development opportunities globally and provides formal exclusivity in the North American market. CHAR has the technology rights to all the equipment intellectual property, including patents and designs, which will allow the Company to more efficiently lead the engineering, procurement and manufacturing of the entire High Temperature Pyrolysis (“HTP”) system. This agreement will streamline the design process, reduce overheads and delivery times, and will...

Continue reading

Rritual Superfoods Announces Closing of Bought Deal

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE U.S./ VANCOUVER, British Columbia, Sept. 10, 2021 (GLOBE NEWSWIRE) — Rritual Superfoods Inc. (“Rritual” or the “Company”) (RSF, RSF.WT) is pleased to announce announced that it has closed its previously announced “bought deal” public offering and raised total gross proceeds of $4,000,000 (the “Offering”). On August 24, 2021, the Company entered into an underwriting agreement for a public offering of units (“Units”) of the Company (the “Offering”) and on September 3, 2021, the Company obtained a receipt for its final prospectus (the “Final Prospectus”) filed with the securities regulatory authorities in the provinces of British Columbia, Alberta and Ontario. The Offering was underwritten by Clarus Securities Inc. (the “Underwriter”). Each Unit consists of one...

Continue reading

NexImmune to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

GAITHERSBURG, Md., Sept. 10, 2021 (GLOBE NEWSWIRE) — NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced that Scott Carmer, Chief Executive Officer, will participate in a fireside chat during the Morgan Stanley 19th Annual Global Healthcare Conference today, September 10, 2021 at 1:15p.m. Eastern time. The webcast will be accessible on the Investor Relations page of NexImmune’s website at Events and Presentations | NexImmune, Inc. A replay of the presentation will be available at the same location for 30 days following the conference. About NexImmune NexImmune is a clinical-stage biotechnology company developing a novel approach to immunotherapy...

Continue reading

WSGF Announces Plans To Launch Vaycaychella 2.0 In November With New Functions To Include Cryptocurrency And Banking Services

Dallas, Texas, Sept. 10, 2021 (GLOBE NEWSWIRE) — World Series of Golf, Inc. (OTC Pink: WSGF) (“WSGF”) today announced plans to launch its Vaycaychella App Version 2.0 in November of this year. WSGF, through its operating subsidiary, Vacycaychella, earlier this year launched a Peer To Peer (P2P) Short Term Rental Property Purchase Application targeting the $87 billion vacation rental market. Vaycaychella 2.0 is slated to include functionality for investors to make fractional investments in vacation rental property businesses through the purchase of cryptocurrency. Version 2.0 will also include access for vacation property business operators to online banking services to include a Visa Debit Card. The Vaycaychella App allows anyone and everyone access to purchasing a short-term rental vacation property that can be listed...

Continue reading

Regarding Board Member’s notification of resignation from the office

On 10th of September 2021 AB Klaipėdos Nafta (hereinafter – KN) received a formal notice by the independent Board Member Ian Bradshaw regarding his resignation from the position as the Board member of KN from 1st  of October 2021. Comment by the Company management: On behalf of the KN management team we would like to extend our appreciation for our colleague Ian Bradshaw for his contribution as an independent KN Board member to the achievement of the long-term strategic goals of KN and his continuous focus on progress in all the areas of activities. Ian’s competence and professionalism has significantly contributed to the development of the KN long-term strategy, company’s establishment, and accomplishments in the international LNG business segment, as well as successful further development of Klaipėda LNG terminal project. In the face...

Continue reading

Artisan Partners Asset Management Inc. Announces Michael Cirami, Michael O’Brien and Sarah Orvin Have Joined the Firm

MILWAUKEE, Sept. 10, 2021 (GLOBE NEWSWIRE) — Artisan Partners Asset Management Inc. (NYSE: APAM) announced today that Michael Cirami, CFA, Michael O’Brien, CFA and Sarah Orvin, CFA have joined Artisan Partners to build the firm’s newest autonomous investment franchise. At Artisan Partners, Mr. Cirami, Mr. O’Brien and Ms. Orvin will develop active, differentiated strategies with broad exposure to the emerging markets debt asset class. The firm plans to launch the team’s initial strategies during the first half of 2022. Mr. Cirami joins the firm as managing director and lead portfolio manager. Mr. Cirami previously spent the last 18 years at Eaton Vance where he was co-director of emerging markets and a portfolio manager on Eaton Vance’s emerging markets team. Mr. O’Brien joins Artisan Partners as managing director and head of global...

Continue reading

Gradual closure of stores specialised in footwear sales

TKM King AS, subsidiary of Tallinna Kaubamaja Group, will gradually close its ABC KING and SHU physical stores that are specialised in footwear sales during 2022. The Group will continue footwear sales through e-channels, in Kaubamaja and in larger Selver stores. At present, there are no plans to sell shares of TKM King AS, termination of the company neither change the composition of the management board. The closure decision does not have significant impact on the Group’s financial results. Raul PuuseppChairman of the Management BoardTel +372 731 5000

Continue reading

Inventiva’s 2021 First-Half Financial Results Presentation

Daix (France), September 10, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today announced that its management team will host a webcast to present the Company’s first-half financial results for 2021 on Tuesday, September 21, 2021. Inventiva’s 2021 first-half financial results will be released on Monday, September 20, 2021 at 4:00 pm (New York), 10:00 pm (Paris).   Frédéric Cren, Chairman, CEO and cofounder of Inventiva and Jean Volatier, Chief Financial Officer of Inventiva, will hold a conference call in English, followed by a Q&A session, on Tuesday, September 21, 2021 at 8:00 am...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.